Effect of High-Dose Quadrivalent Influenza Vaccine (Efluelda®) versus Standard-Dose (QIV-SD), in subjects 65 years of age and older on innate immunity, including gene expression.
Latest Information Update: 23 Apr 2024
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Acronyms INFLUOMICS
Most Recent Events
- 05 Aug 2022 Status changed from recruiting to completed.
- 13 Oct 2021 New trial record